Epidemiology of 10 Cancer Types in Indonesia: A Multicenter Study
Sari
Cancer remains one of the largest contributors to the burden of health and mortality around the world. A study estimated 19.3 million new cases of cancer in the year 2020. GLOBOCAN 2020 provides a list of the most common cancers in the world which are prostate, lung, and colorectal cancers in men and breast, colorectal, and lung cancer in women. Naturally, different sociodemographic and geographic characteristics will cause disparities in these estimates. Since valid epidemiological data on cancer types in Indonesia remains unavailable, this study intended to provide data on the pattern of distribution of the 10 most common cancer types amongst various hospitals in Indonesia. This was achieved through the collection of registries and/or medical records that were obtained from March to September 2022. The data were then sorted and analyzed using SPSS 20.0. The resulting epidemiological data in multi-centers in Indonesia yielded a similar top 10 most common cancers trend with the GLOBOCAN 2020 worldwide incidence, although some differences were seen. A universal similarity that is found amongst different databases seems to be the prevalence of breast cancers, which always ‘champions’ all databases as the most common cancers among women. This provides a reflection for policy and decision makers for their prompt action to promote the prevention, diagnosis, and treatment of cancers in Indonesia, especially breast cancers.
Kata Kunci
Teks Lengkap:
PDF (English)Referensi
Bochen Cao, Gretchen A. Stevens JH and DMF. WHO methods and data sources for country-level causes of death. World Heal Organ [Internet]. 2020;(December). Available from: http://www.who.int/gho/mortality_burden_disease/en/index.html
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021 Feb;0:1–41.
Akinyemiju T. Chapter 9 - Epigenetic Biomarkers in Cancer Epidemiology. In: Saldanha S, editor. Epigenetic Mechanisms in Cancer [Internet]. Boston: Academic Press; 2018. p. 223–41. (Translational Epigenetics; vol. 3). Available from: https://www.sciencedirect.com/science/article/pii/B9780128095522000097
Gondhowiardjo S, Christina N, Ganapati NPD, Hawariy S, Radityamurti F, Jayalie VF, et al. Five-Year Cancer Epidemiology at the National Referral Hospital: Hospital-Based Cancer Registry Data in Indonesia. JCO Glob Oncol. 2021;(7):190–203.
Gondhowiardjo S, Sekarutami SM, Giselvania A, Octavianus S, Assegab MI. Improving access to radiation therapy in Indonesia. Appl Radiat Oncol. 2019;(June):17–21.
MASI AT. Potential Uses and Limitations of Hospital Data in Epidemiologic Research. Am J Public Health Nations Health. 1965;55(5):658–67.
Mattiuzzi C, Lippi G. Current Cancer Epidemiology glossary. J Epidemiol Glob Health. 2019;9(4):217–22.
Breast Cancer. Food Nutr Dis Manag. 2020;596–609.
Widiana I, Irawan H. View of Clinical and Subtypes of Breast Cancer in Indonesia. Asian Pac J Cancer Care. 2020;5(4):281–5.
CDC. Incidence and Relative Survival by Stage at Diagnosis for Common Cancers. Division of Cancer Prevention and Control; 2021.
Cone EB, Marchese M, Paciotti M, Nguyen DD, Nabi J, Cole AP, et al. Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common Cancers. JAMA Netw open. 2020;3(12):e2030072.
DOI: https://doi.org/10.32532/jori.v13i2.161 <
Article metrics
Abstract views : 324 | views : 1207Refbacks
- Saat ini tidak ada refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.